Showing results (11-20 of 110) with videos related to
Sort By:
Pageof 11
Seminars in Nephrology|July 10, 2007
Chronic allograft nephropathyNidyanandh Vadivel, Stefan G Tullius, Anil ChandrakerClinical Transplantation|September 3, 2015
Recombinant PTH therapy for severe hypoparathyroidism after kidney transplantation in pre-transplant parathyroidectomized patients: review of the literature and a case reportTammy Hod, Leonardo V Riella, Anil ChandrakerCurrent Opinion in Nephrology and Hypertension|October 9, 2013
Beyond calcineurin inhibitors: emerging agents in kidney transplantationKassem Safa, Leonardo V Riella, Anil ChandrakerClinics in Laboratory Medicine|February 3, 2019
Novel Targets of Immunosuppression in TransplantationHo Sik Shin, Ivica Grgic, Anil ChandrakerCurrent Protein & Peptide Science|May 8, 2019
Potential Roles of Siglecs in the Regulation of Allo-Immune ReactionSongjie Cai, Jing Zhao, Takuya Ueno, et al.Clinical Journal of the American Society of Nephrology : CJASN|May 24, 2018
Regulatory T Cells and Kidney TransplantationPaloma Leticia Martin-Moreno, Sudipta Tripathi, Anil ChandrakerSeminars in Nephrology|March 30, 2024
Adoptive Immune Effector Cell Therapies in Cancer and Solid Organ Transplantation: A ReviewBrittany Schreiber, Sudipta Tripathi, Sarah Nikiforow, et al.Antiviral Therapy|May 17, 2007
Inhibition of Simian virus 40 large T antigen helicase activity by fluoroquinolonesSyed Hamid Ali, Anil Chandraker, James A DeCaprioCurrent Opinion in Organ Transplantation|August 13, 2016
Donor-specific antibodies and antibody-mediated rejection in vascularized composite allotransplantationAnnemarie Weissenbacher, Alexandre Loupy, Anil Chandraker, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|April 21, 2006
Modifying graft immunogenicity and immune response prior to transplantation: potential clinical applications of donor and graft treatmentPaulo N A Martins, Anil Chandraker, Stefan G TulliusPageof 11